Nosopharm Signs Partnership With Inrae and University of Montpellier to Develop New Anti-Infectives

Lyon, France, March 15, 2022—Nosopharm, specialized in exploring unconventional sources of antibiotics to discover new drugs to fight antimicrobial resistance, today announces that it has signed a collaboration agreement with the DGIMI laboratory (UMR1333: Diversity, Genomes and Insects-Microorganisms Interactions). DGIMI falls under the authority of the French National Research Institute for Agriculture, Food, and the Environment (INRAE) and the University of Montpellier. The aim of this collaboration is to produce chemical libraries of new bioactive molecules which will feed into Nosopharm’s anti-infective screening campaigns against antibiotic resistance. ‘France Relance’, the French government investment plan created following the Covid-19 pandemic, brings financial support to this new collaboration between Nosopharm, INRAE and University of Montpellier.
More info >>